Rote Liste® Analytics - Data-Driven Decisions
Strategic Clarity for Your Medicines Information with Rote Liste Analytics
Rote Liste Analytics is a centralized reporting solution built on the structured data foundation of the Rote Liste Therapeutics Database (TDB). It consolidates data from multiple sources, transforms it into actionable insights, and supports evidence-based strategic and operational decision-making.
Benefits of Rote Liste Analytics
Detailled Data Insights
Flexible Reporting
Actionable Insights
Continuous Development
Ongoing enhancement of the platform through close collaboration with customers, ensuring practical and future-oriented solutions.
.png?width=300&height=194&name=Rote%20Liste%20Analytics%20Seitenaufrufe%20Sceenshot%20(1728%20x%201117%20px).png)
The Tool
Empowering Strategic and Operational Decisions with Reliable Data
Rote Liste Analytics provides pharmaceutical companies with a robust, data-driven foundation for decision-making across all business functions, from executive management and business teams to Market Access and Regulatory Affairs. By structuring and visualizing relevant usage data, the platform helps identify trends, opportunities, and areas for action. This enables organizations to make strategic and operational decisions more quickly, more accurately, and based on transparent, reliable insights.
Page Views
More than 150,000 page views are recorded daily across our platforms.
Search Queries
More than 170,000 searches are conducted across our platforms every day.
AI-Powered Queries
We process more than 25,000 AI-assisted search requests each day..

Comprehensive Insights into the Use of Rote Liste Databases
Rote Liste Analytics provides detailed insights into how healthcare professionals and patients interact with the information available on the Rote Liste platforms. User behavior, page views, and search interests can be analyzed to uncover trends related to active ingredients or therapeutic areas, identify seasonal patterns, and measure engagement surrounding major medical congresses, product launches, or marketing initiatives.
The platform continues to evolve through close collaboration with our customers, ensuring that reporting capabilities remain aligned with industry needs and address real-world business questions effectively.
Stay informed
Subscribe to our newsletter for pharmaceutical companies to receive regular updates from Rote Liste.
What Our Customers Say About Us
Pharmacist / Deputy Information Officer
mibe GmbH Arzneimittel
Eisai would like to support patients, their relatives, and healthcare professionals as effectively as possible with up‑to‑date product information texts before and during therapy with our medicinal products.
Using the various services offered by Rote Liste brings us one step closer to this goal.
Medical Director
Eisai GmbH